Abstract
Increased prevalence of methicillin-resistant Staphylococcus aureus (MRSA) has become a major threat to the health sector worldwide due to their virulence, limited therapeutic options and their distribution in both hospital and community settings. Discovery and development of new anti-MRSA agents as alternatives to the very few antibiotics left in the armamentarium are, thus, urgently required. Recently, an efflux mechanism in MRSA has been identified as one of the main contributors of resistance towards various structurally unrelated antibiotics. The potential of reserpine (a phytoalkaloid) as efflux pump inhibitor (EPI) against various microbes remains limited as the concentration needed for inhibition is toxic to humans. This study therefore aimed to evaluate 13 alkaloid compounds as potential inhibitory agents and/or potential EPIs against a panel of three MRSA isolates which not only differ in their susceptibility to vancomycin (amongst the last drugs available to treat serious MRSA infection), but also exhibited active efflux activity. Results indicated berberine’s moderate inhibitiory activity against two MRSA isolates scoring a minimum inhibitory concentration (MIC) value of 125 μg/ml. Notable efflux inhibitory activity (ranging from two- to eightfold Ethidium Bromide MIC reduction) meanwhile was detected from quinine, piperine and harmaline using reserpine as the positive control. Findings from this study support the opinion that a vast number of potential phytocompounds with pharmacological potential await discovery. Therapeutic application of these compounds, however, warrants further investigation to ascertain their pharmacodynamics and safety aspects.
Similar content being viewed by others
References
Alborzi A, Ba Pourabbas, Salehi H et al (2000) Prevalence and pattern of antibiotic sensitivity of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in Shiraz-Iran. Iran J Med Sci 25:1–8
Bailie GR, Neal D (1998) Vancomycin ototoxicity and nephrotoxicity. A review. Med Toxicol Adverse Drug Exp 3:376–386
Bao B, Sun Q, Yao X et al (2005) Cytotoxic bisindole alkaloids from a marine sponge spongosorites sp. J Nat Prod 68:711–715
Biavasco F, Giovanetti E, Montanari MP et al (1991) Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J Antimicrob Chemother 27:71–79
Birdsall TC, Kelly GS (1997) Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 2:94–103
Centers for Disease Control, Prevention (2002) Staphylococcus aureus resistant to vancomycin-United States. Morb Mortal Wkly Rep MMWR 51:565–567
Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12:58–564
DeMarco CE, Cushing LA, Frempong-Manso E et al (2007) Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother 51:3235–3239
Elisabetsky E, Costa-Campos L (2006) The alkaloid alstonine: a review of its pharmacological properties. Evid Based Complement Altern Med 3:39–48
Eloff JN (1998) A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 64:711–713
Foster TJ (2004) The Staphylococcus aureus “Superbug”. J Clin Invest 114:1693–1696
Gibbons S (2004) Anti-staphylococcal plant natural products. Nat Prod Rep. 21:263–277
Gibbons S, Oluwatuyi M, Kaatz GW (2003) A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother 51:13–17
Guz NR, Stermitz FR, Johnson JB et al (2001) Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pumps: structure-activity relationships. J Med Chem 44:261–268
Hasse M (2002) Alkaloids: nature’s curse or blessing? Zurich. Wiley, VCH
Hiramatsu K, Hanaki H, Ino T et al (1997) Mehicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135–136
Khan IA, Mirza ZM, Kumar A et al (2006) Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 50:810–812
Lomovskaya O, Watkins WJ (2001) Efflux pumps: their role in antibacterial drug discovery. Curr Med Chem 8:1699–1771
Lukacs GL, Rotstein OD, Grinstein S (1991) Determinants of the phagosomal pH in macrophages. In situ assessment of vacuolar H(+)-ATPase activity, counterion conductance, and H + “leak”. J Biol Chem 266:2458–24540
Mashour NH, Lin GI, Frishman WH (1998) Herbal medicine for the treatment of cardiovascular disease - clinical considerations. Arch Intern Med 158:2225–2234
Mikos-Schild S (1998) MRSA-what every health care provider should know. Today’s Surg Nurse 20:20–24
National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial disk susceptibility tests, approved standard M100–S14. National Committee for Clinical Laboratory Standards, Villanova, Pa, pp 40–47
Oluwatuyi M, Kaatz GW, Gibbons S (2004) Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochem 65:3249–3254
Paulsen IT, Brown MH, Skurray RA (1996) Proton-dependent multidrug efflux systems. Microbiol Rev 60:60–575
Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20–51
Saiful AJ, Mastura M, Zarizal S et al (2006) Detection of methicillin-resistant Staphylococcus aureus using mecA/nuc genes and antibiotic susceptibility profile of Malaysian clinical isolates. World J Microbiol Biotechnol 22:1289–1294
Saiful AJ, Mastura M, Zarizal S et al (2008) Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). J Basic Microbiol 48:245–251
Sharma P, Varma MVS, Chawla HPS et al (2005) In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Il Farmaco 60:874–883
Sieradzki K, Tomasz A (1997) Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol 179:2557–2566
Smigan P, Majernik A, Polak P et al (1995) The presence of H + and Na(+)-translocating ATPases in Methanobacterium thermoautotrophicum and their possible function under alkaline conditions. FEBS Lett 371:119–122
Spikes JD (1998) Photosentizing properties of quinine and synthetic antimalarials. J Photochem Photobiol B 42:1–11
Stavri M, Piddock LJ, Gibbons S (2007) Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 59:1247–1260
Tambyah PA, Habib AG, Toon-Mae BN et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually “Healthcare associated”. Infect Cont Hosp Epidemiol 24:436–438
Wieczorek H, Putzenlechner M, Zeiske W et al (1991) A vacuolar-type proton pump energizes K +/H + antiport in an animal plasma membrane. J Biol Chem 266:15340–15347
Zloh M, Gibbons S (2004) Molecular similarity of MDR inhibitor. Int J Mol Sci 5:37–47
Acknowledgments
The authors acknowledge the funding support provided by the Forest Research Institute Malaysia (TGP - 40-300-40-3007), and Ministry of Science, Technology and Innovation, Malaysia (eIRPA - 30-300-40-3010), and thank Mrs. Hannan Abdul Wahab and Mr. Izanudin Zakaria for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the FRIM’s Young Scientist Grant No. 40-300-40-3007 and the Intensified Research in Priority Areas (IRPA) Grant No. 30-300-40-3010 from the Ministry of Science, Technology and Innovation, Malaysia.
Rights and permissions
About this article
Cite this article
Mohtar, M., Johari, S.A., Li, A.R. et al. Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA). Curr Microbiol 59, 181–186 (2009). https://doi.org/10.1007/s00284-009-9416-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-009-9416-9